Jane Street’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240K Sell
61,802
-145,035
-70% -$356K ﹤0.01% 9722
2025
Q4
$403K Buy
206,837
+58,649
+40% +$96.2K ﹤0.01% 8174
2025
Q3
$125K Sell
148,188
-142,181
-49% -$104K ﹤0.01% 10018
2025
Q2
$210K Buy
290,369
+218,512
+304% +$164K ﹤0.01% 8455
2025
Q1
$61.9K Sell
71,857
-36,688
-34% -$54.5K ﹤0.01% 8953
2024
Q4
$182K Buy
108,545
+70,863
+188% +$169K ﹤0.01% 8469
2024
Q3
$107K Sell
37,682
-25,020
-40% -$64.8K ﹤0.01% 8972
2024
Q2
$147K Buy
62,702
+31,947
+104% +$83.4K ﹤0.01% 8587
2024
Q1
$90.4K Sell
30,755
-21,933
-42% -$62.2K ﹤0.01% 8562
2023
Q4
$158K Buy
52,688
+39,790
+308% +$114K ﹤0.01% 8372
2023
Q3
$40.8K Sell
12,898
-10,363
-45% -$33.7K ﹤0.01% 8195
2023
Q2
$90K Sell
23,261
-10,189
-30% -$29.4K ﹤0.01% 8046
2023
Q1
$92.7K Buy
+33,450
New +$70.2K ﹤0.01% 8260
2022
Q3
Sell
-12,459
Closed -$34K 10180
2022
Q2
$34K Sell
12,459
-16,440
-57% -$61.2K ﹤0.01% 9016
2022
Q1
$125K Buy
28,899
+16,456
+132% +$67.5K ﹤0.01% 9342
2021
Q4
$65K Sell
12,443
-516
-4% -$2.76K ﹤0.01% 9431
2021
Q3
$80K Sell
12,959
-160,743
-93% -$1.28M ﹤0.01% 9385
2021
Q2
$1.75M Sell
173,702
-18,717
-10% -$203K ﹤0.01% 4586
2021
Q1
$2.65M Buy
+192,419
New +$2.67M ﹤0.01% 3496

Other funds holding NAUT

Jane Street's NAUT Position: Q1 2026 in Review

Jane Street reduced its Nautilus Biotechnolgy (NAUT) stake by 70% in Q1 2026, selling an estimated $356K and leaving 61,802 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #9722.

Jane Street first reported a position in NAUT in Q1 2021 and has held it in 19 quarters since. The position peaked at $2.65M in Q1 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Jane Street held 61,802 shares of Nautilus Biotechnolgy worth $240K as of Q1 2026.
  • Jane Street sold 145,035 Nautilus Biotechnolgy shares in Q1 2026, an estimated $356K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9722 holding.
  • Jane Street first reported a position in Nautilus Biotechnolgy in Q1 2021 and has held it in 19 quarters since.
  • Jane Street's Nautilus Biotechnolgy position peaked at $2.65M in Q1 2021.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.